Hudson Bay Capital Management LP Repligen Corp Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Repligen Corp stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 40,000 shares of RGEN stock, worth $5.78 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
40,000
Previous 55,000
27.27%
Holding current value
$5.78 Million
Previous $6.93 Million
14.15%
% of portfolio
0.03%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$923 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$729 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$235 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$205 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.02B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....